[Cost/benefit analysis of a regional drug surveillance center].
Mignot
G
G
Chichmanian
R M
RM
Spreux
A
A
Bernard
G
G
D003151:Community Health Centers / Q000191:economics*; D003362:Cost-Benefit Analysis; D003951:Diagnostic Errors; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions; D005602:France; D006801:Humans; D008508:Medication Errors; D011358:Product Surveillance, Postmarketing; D012189:Retrospective Studies
Vers l'analyse coût/bénéfice d'un centre régional de pharmacovigilance.